Robert Coffin

Robert Coffin is currently Founder, CEO and Director of Replimune Ltd, Oxford, UK.

Content by Robert Coffin:

About the author

| Charlotte Barker, William Aryitey, Michael Schubert, James Strachan, Karim Dabbagh, Ann Hayes, Thomas Conrads, Anthony Quinn, Niclas Nilsson, Eric Topol, Benoit Arveiler, Didier Raoult, Ewan McNay, Tamara Minko, Jennifer Van Eyk, Cathy Merry, Diane Hoffman-Kim, Robert Coffin, Helen Lambert , Julian Solway, Richard Holland, Jan Johannessen, Ameeta Parekh, Bradley Hyman, Michela Gallagher

Outside the Lab Cancer

Oncotherapy Goes Viral

| Robert Coffin

Robert Coffin tells the bench-to-bedside story of how the first FDA-approved oncolytic virotherapy, talimogene laherparepvec (T-VEC), was translated from a colleague’s cold sore to a potential global game changer.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register